SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 53 filers reported holding SPRING BK PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 953,301 | $11,487,000 | 1.01% |
| Morse Asset Management, Inc | 190,050 | $2,290,000 | 0.60% |
| Stonepine Capital Management, LLC | 71,050 | $856,000 | 0.50% |
| SECTORAL ASSET MANAGEMENT INC | 291,656 | $3,514,000 | 0.37% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 277,363 | $3,342,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 73,000 | $673,000 | 0.32% |
| TIEDEMANN ADVISORS, LLC | 412,049 | $4,964,000 | 0.29% |
| CAXTON CORP | 20,986 | $253,000 | 0.23% |
| Sofinnova Investments, Inc. | 189,646 | $2,285,000 | 0.20% |
| Private Capital Advisors, Inc. | 52,335 | $631,000 | 0.17% |